Atkinson P J, Hancock D A, Acharya V N, Parsons F M, Proctor E A, Reed G W
Br Med J. 1973 Dec 1;4(5891):519-22. doi: 10.1136/bmj.4.5891.519.
The measurement of bone loss in patients undergoing maintenance dialysis over a period of two and a half years is reported. The tendency to lose bone is a likely event in renal failure, but depends more on the individual patient than on the type of dialysis used, provided that steps are taken to prevent avoidable calcium loss during dialysis. Vitamin D therapy was an important factor in preventing bone loss in some cases. The tendency to lose bone more readily when both kidneys were absent may have reflected a deficiency of 1-25 dihydrocholecalciferol. On the other hand, bone loss was also observed in transplanted patients. The need to measure bone loss at regular intervals once renal failure has been diagnosed is stressed.
报告了维持性透析患者两年半期间骨质流失的测量情况。肾衰竭患者有骨质流失的倾向,但在采取措施防止透析期间可避免的钙流失的情况下,骨质流失更取决于个体患者而非所使用的透析类型。维生素D疗法在某些情况下是预防骨质流失的重要因素。双侧肾脏缺失时更易发生骨质流失的倾向可能反映了1,25 - 二羟胆钙化醇的缺乏。另一方面,移植患者也观察到骨质流失。强调一旦诊断出肾衰竭就需要定期测量骨质流失情况。